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Abstract 1 
The human gut microbiome plays a key role in human health 1. but 16S characterization lacks quantitative 2 
functional annotation7 .  The fecal metabolome provides a functional readout of microbial activity and could 3 
be used as an intermediate phenotype mediating these interactions 8. In the first comprehensive description 4 
of the fecal metabolome, examining 1116 metabolites of 786 individuals from a population-based twin 5 
study (TwinsUK)t the fecal metabolome was found to be only modestly influenced by host genetics 6 
(h2=17.9%). One replicated locus at the NAT2 gene was associated with fecal metabolic traits. The fecal 7 
metabolome largely reflects gut microbial composition, explaining on average 67.7% (±18.8%) of its 8 
variance. It is strongly associated visceral fat mass illustrating potential mechanisms underlying the well-9 
established microbial influence on abdominal obesity. Fecal metabolomic profiling appears  as a novel tool 10 
to explore mechanistic links between microbiome composition, host phenotypes and heritable complex 11 
traits. 12 
  13 
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There is growing evidence that the gut microbiome contributes to maintaining homeostasis of host 1 
metabolism1. Disruption of this intricate system is associated with diseases such as obesity2,3 and 2 
insulin resistance4. Metabolomics and the gut microbiome are strongly related, with microbes 3 
producing many of the body’s chemicals, hormones and vitamins5. The gut microbiome has been 4 
reported to have an effect on circulating levels of several metabolites such as branched-chain amino 5 
acids (BCAA) potentially causing insulin resistance4. However, despite the advances of next 6 
generation sequencing platforms, which allow profiling of complex microbial communities using 16S 7 
sequencing, annotation is sparse. Moreover, the microbiome only codes microbial possibilities 8 
rather than their actual activity and cannot differentiate between alive and dead microbes6, nor 9 
determine the transcriptional activity of the genes within each bacterial genome7. Fecal 10 
metabolomics, however, reports specifically on the metabolic interplay between the host, diet and 11 
the gut microbiota8 and complements sequencing-based approaches with  a functional readout of 12 
the microbiome. Here we provide the first comprehensive description of the fecal metabolome in a 13 
large population-based setting with the additional advantage of the twin model. We report (i) fecal 14 
metabolites associations with age, gender and obesity; (ii) host genetic influences; and (iii) uni- and 15 
multivariable dependencies with the gut microbiome. 16 
We analyzed fecal samples of 786 predominantly female twins of the TwinsUK cohort, aged 65.2 17 
(±7.6), with an average BMI of 26.1 (±4.7) (Supplemental Table S1) and we replicated our genetics 18 
results in an independent sample of 230 individuals, aged 66.9 (±8.6) with an average BMI of 27.2 19 
(±5.2). Untargeted metabolomics profiling of the participants’ fecal samples was conducted by 20 
Metabolon, Inc., using mass spectrometry, measuring a total of 1116 metabolites, 866 of them with 21 
known chemical identity. Among the metabolites identified, 570 were common and detected in at 22 
least 80% of the samples, while 345 were detected in at least 20% but in less than 80% of all samples 23 
(Fig 1a). The latter were analyzed as dichotomous traits (present/absent in a sample) and 24 
metabolites measured in less than 20% of the samples were discarded from further analysis. 647 of 25 
the 1116 measured metabolites were not detected in blood samples of the same individuals profiled 26 
on the same platform (Fig 1b). This suggests that the fecal metabolome provides complementary 27 
information to blood metabolomics. We did not find significant associations between 915 fecal 28 
metabolites and age after correcting for multiple testing. However, a multivariate partial least 29 
squares discriminant analysis incorporating all the common 570 metabolites could distinguish the 30 
oldest decile (>75 years) from the youngest decile (<56 years.) of the study population (AUC=0.71, 31 
p=6.8×10-6, Fig 2b) and one metabolite, phytanate, was significantly different between the oldest 32 
and youngest deciles (p=5.0×10-3) (Fig 2a), suggesting non-linear associations between the fecal 33 
metabolome and agem in line with previous reports on the effects of age on the gut microbiome9,10.  34 
BMI was associated with eight metabolites at an FDR (Benjamini-Hochberg) of 5%: five fecal lipids, 35 
including arachidonate (β [95% CI] = 0.13 [0.07:0.19], p=1.1×10-5), the hemoglobin metabolite 36 
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bilirubin (β [95% CI] = 0.13 [0.06:0.19], p=8.9×10-5) and two unknown metabolites (Supplemental 1 
Table S2). We then looked for associations with visceral fat mass, a measure of abdominal obesity, 2 
correcting for BMI, and found a total of 102 statistically significant associations (FDR<5%, 13 passing 3 
Bonferroni correction), which together explain 28.4% of the observed total variance of visceral fat 4 
(p<2.2×10-16) (Supplemental Table 2).  We find only 8 metabolites associated with BMI whereas 102 5 
associate with visceral fat (after adjusting for BMI). BMI is an imprecise measure of adiposity and 6 
measures overall mass without distinction between lean and fat mass11. However, the gut 7 
microbiome is known to play a major role in fatty acid metabolism and adiposity which may be 8 
better reflected by visceral fat measures12,13. Emerging evidence suggests a role for the intestinal 9 
microbiota in visceral development by interacting with dietary components14. We have previously 10 
shown strong associations between visceral fat mass and the gut microbiome composition15,16. The 11 
much larger number of fecal metabolite associations with visceral fat than with BMI are consistent 12 
with these findings and highlight the strong influence of metabolic processes in the gut influencing 13 
abdominal adiposity. 14 
 Visceral fat-associated metabolites were significantly enriched for amino acids (43 metabolites, 15 
enrichment p<2×10-4) but also included 14 fatty acids, including arachidonate (β=5.07 [2.55:7.59], p= 16 
8.2×10-5), 8 nucleotides, 6 sugars and 6 vitamins. The strong association between the fecal 17 
metabolome and central obesity confirms hypotheses on the involvement of microbial amino acid 18 
metabolism in obesity and suggests new mechanisms, such as microbial vitamin B metabolism. We 19 
have previously found several microbe families associated with lower visceral fat mass15 and 20 
reduced weight gain in germ-free mice receiving human fecal transplants17. By analyzing the fecal 21 
metabolome, we found the abundance of the same families to be strongly associated with 22 
decreased abundance of amino-acids (see below), suggesting that their association with visceral fat 23 
may be mediated by the availability of amino acids (Fig 3). This may be due to increased utilization or 24 
decreased production of amino acids by these bacteria, or the result of more complex host-microbe 25 
interactions.  26 
The gut microbiome is heritable17,18 and we found a heritable variance component for 210 OTUs, 27 
which explained on average 22.7% of the observed total variance. To test whether host genetic also 28 
influences the fecal metabolome we first estimated its heritability, taking advantage of the twin 29 
structure in our data (148 MZ pairs, 155 DZ pairs) using structural equation modelling. For 428 30 
metabolites the best fitting model contained a heritable variance component (A), which explained 31 
on average 17.9% (±9.7%) of the metabolite variation. Long chain fatty acid-containing metabolites, 32 
such as 1-palmitoyl-2-arachidonoyl-GPC (H2=60.7% [95% CI 43.4:78.0]) and stearoylcarnitine 33 
5 
 
(H2=54.3% [36.4:72.3]), were amongst the most heritable metabolites. For 279 metabolites, 1 
including the coffee-metabolite 5-acetylamino-6-amino-3-methyluracil (C=30.3% [20.0:40.6]), the 2 
best fitting model was the CE model, where the common environment component (C) explained on 3 
average 14.8% (±8.1%) of the variance. For the remaining 208 metabolites, the best fitting model 4 
was the E model where the entire variation of the metabolite is due to individual differences such as 5 
the microbiome or individual diet (Supplemental Table 2, Fig S1). We found a significantly stronger 6 
environmental effect on lipids than other metabolites (enrichment p-value < 2×10-4). 7 
We subsequently conducted GWAS for the 428 metabolites with a heritable component and 8 
identified three metabolites (the amino-acid 3-phenylpropionate and two lipids eicosapentaenoate 9 
and 3-hydroxyhexanoate) significantly associated with genetic loci after correcting for multiple 10 
testing (p<1.2×10-10=5×10-8/428) (Table 1, Fig 5a). We also tested for genetic associations of 11 
metabolites ratios, which can be better proxies for chemical reactions than single metabolites19. 12 
After correcting for 31,226 tested ratios, the ratio of 5-acetylamino-6-amino-3-methyluracil and 1,3-13 
dimethylurate was associated with a locus on chromosome 8 (rs35246381, p=7.0×10-21, p-14 
gain=7.5×109) (Table 1, Fig 5b). We replicated our GWAS results in an independent sample of 230 15 
individuals. Out of 4 loci tested, only the metabolite ratio of 5-acetylamino-6-amino-3-methyluracil 16 
and 1,3-dimethylurate was significantly associated in the replication cohort (p=3.6×10-10; meta-17 
analysis p=3.3×10-36). The two metabolites 5-acetylamino-6-amino-3-methyluracil and 1,3-18 
dimethylurate are products of caffeine metabolism20. The associated locus at the NAT2 gene codes 19 
for a N-acetyltransferase, which catalyzes the degradation of caffeine metabolites21 (Supplementary 20 
Fig S5). Associations of this locus with other caffeine-metabolites (1-methylxanthine, 4-21 
acetamidobutanoate and 1-methylurate) have been previously observed in blood22 and urine23 and 22 
likely reflect efficiency of the degradation of caffeine. We then explored if there were any eQTLs or 23 
other functional variants in strong LD with the top SNP. Although we found three eQTLs 24 
(rs11996129, rs1112005, rs1799930) for NAT224, these are only in weak LD (r2<0.16) with 25 
rs3524638125 and the associations between these SNPs and the metabolite ratio is weaker than that 26 
of the top SNP (p=3.6×10-10 vs p=9.4×10-7). The tissues where the  expression of NAT2 is highest, 27 
after liver, are in the jejunal and colonic mucosa, duodenum colon and small intestine26,*. This is 28 
consistent with polymorphisms in the NAT2 gene being associated with the concentration of caffeine 29 
derived metabolites in feces. We explored the relationship between caffeine and the fecal 30 
metabolites 5-acetylamino-6-amino-3-methyluracil and 1,3-dimethylurate, and find that their ratio is 31 
positively correlated with both coffee intake and serum caffeine levels (Supplementary Fig S5). 32 
These genetic association data illustrate how part of the complex metabolism of caffeine takes place 33 
                                                          
*  http://bgee.org/?page=gene&gene_id=ENSG00000156006 
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in the intestine before reaching the liver and that the links between the host genetic makeup and 1 
xenobiotic concentrations can be captured by fecal metabolites. In addition to caffeine, the NAT2 2 
enzyme is also involved in metabolism of various xenobiotics and is therefore related to variance in 3 
drug response and toxicity27. There is, work showing that the composition of the gut microbiome 4 
regulates xenobiotic enzymes, e.g.. the expression of NAT2 is 1.5 higher in germ free animals  than in 5 
the large intestine of control animals28. Taken together with our results, these data fit with a picture 6 
of xenobiotic metabolism being regulated jointly by host genetic variation and gut microbiome 7 
composition. 8 
We then investigated the extent to which the metabolome reflect metabolic processes of the gut 9 
microbiome. We regressed metabolite levels against microbial diversity (quantified by the Shannon 10 
index), and found that 575 metabolites across all pathways showed a significant association with 11 
microbial diversity at a FDR of 5%, with 347 passing a Bonferroni correction. We estimated the 12 
proportion of variance in each metabolite explained by microbiome composition using the 13 
unweighted UniFrac beta-diversity metric, a measure of overall phylogenetic dissimilarity between 14 
individuals’ microbiota29. We found that gut microbial composition explained a significant proportion 15 
of the observed variance of 710 metabolites, on average 67.7% (±18.8%) of the observed variance, 16 
ranging from 22.1% for 1-linolenoylglycerol to 100% for several amino acids (Table S2). Amongst 17 
others, the microbiome explained a significant proportion of the variance of the 8 BMI-related and 18 
101 of the visceral fat-related metabolites. Xenobiotics showed the strongest associations with 19 
microbial composition (enrichment p-value< 1×10-4), which explained the entire observed variance 20 
for some of them including the B-vitamins nicotinate and pantothenate. 21 
To explore the associations of the fecal metabolome with gut microbes at a finer taxonomic 22 
resolution we regressed each metabolite against the 581 most abundant operational taxonomic 23 
units (OTUs), adjusting for potential confounding factors including Shannon diversity. We found 24 
42,645 significant associations of 907 different metabolites with 579 different OTUs after adjusting 25 
for multiple testing (FDR<5%). We also calculated associations of fecal metabolites with collapsed 26 
taxonomical levels, ranging from genus to phylum level. 264 metabolites were only associated with 27 
microbes at the OTU level, with the remainder also associating with broader taxonomic groupings.  28 
Lastly, to investigate the connectivity of the fecal metabolome with microbes, we calculated a 29 
Gaussian graphical model (GGM) combining 435 common metabolites with a known chemical 30 
identity with 241 OTUs with complete taxonomy assignment to at least genus level. The resulting 31 
model consists of 2553 independent associations, 1035 of them amongst metabolites, 946 amongst 32 
microbes and 572 connecting metabolites and microbes (Supplementary Fig S6).All but 9 variables 33 
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form one connected component. We detect 19 clusters in the largest component, 9 of which contain 1 
both microbes and fecal metabolites and 10 consist of metabolites only. Xenobiotics have higher 2 
node degrees (p<3×10-4) and were more densely connected with OTUs (p<2.4×10-3). Our model 3 
demonstrates the high degree of interrelatedness between gut microbiome and fecal metabolome, 4 
despite the very different technologies used. 5 
In conclusion, although  state of the art metagenomic sequencing allows quantitative and functional 6 
annotation of species and microbial pathways30, 16S sequencing data has limitations including the 7 
lack of quantitative functional annotations. Fecal metabolomics provides a complimentary functional 8 
readout of microbial metabolism as well as its interaction with host and environmental factors. We 9 
have focused on the relationship between fecal metabolites and host and microbial genetics.Future 10 
studies should further investigate the influence of environmental factors, particularly nutrition and 11 
consider the influence of stool frequency/ type on fecal metabolite measurements, as these are 12 
known to be associated with fecal microbiome composition31,32. The fecal metabolome can thus be 13 
used as intermediate phenotype that promotes microbial effects on the host and vice-versa. Using 14 
the associations with obesity, we demonstrate that fecal metabolomics are a useful tool to 15 
complement future genomic and microbiome studies.  16 
Online Methods 17 
Study population 18 
Study participants were 786 twins from the TwinsUK cohort. TwinsUK (a national twin registry) has 19 
been recruited since 1992 through media campaigns and is representative of the population of the 20 
UK in terms of life style33. The study population is predominantly female (93.4% females), with an 21 
average age of 65.2 (±7.6) and an average of BMI of 26.1 (±4.7). Ethical approval by St Thomas’ 22 
Hospital ethics committee; all participants provided informed written consent. 23 
Results of the genome-wide association study were replicated in an independent set of 230 24 
individuals (98.3% female) from the TwinsUK study, aged 66.9 (±8.6) and an average BMI of 27.2 25 
(±5.2) (Supplementary Table S1). 26 
Data collection 27 
Sample collection, DNA extraction, and sequencing of the samples within this study has been 28 
described previously17,18. Briefly, the fecal samples were collected, refrigerated and kept in ice packs 29 
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until they were frozen at -80°C (mostly within 24 hours from collection) before further processing.  A 1 
number of participants (15%) sent their samples by post.  2 
Metabolomics profiling 3 
Metabolite concentrations were measured from fecal samples by Metabolon Inc., Durham, USA, 4 
using an untargeted LC/MS platform as previously described22,34 (see supplemental methods for 5 
details). The median process variability, determined by technical replicates of pooled samples, was 6 
12%. 7 
A total of 1116 different metabolites were measured in the 786 fecal samples, of which 210 were 8 
observed in less than 20% of the samples and thus excluded from further analysis due to lack of 9 
power. 345 metabolites were observed in more than 20% but less than 80% of the samples and were 10 
thus analyzed qualitatively as dichotomous traits (observed in a sample vs. not observed). The 11 
remaining 570 metabolites, which were observed in at least 80% of all samples, were scaled by run-12 
day medians, log-transformed and scaled to uniform mean 0 and standard deviation 1 and analyzed 13 
quantitatively. Metabolite ratios were calculated from the run-day median normalized metabolite 14 
levels and subsequently log-transformed and scaled to a mean of 0 and standard deviation of 1. 15 
We analyzed effects of sample storage time (i) in the fridge before samples were frozen and (ii) in 16 
the freezer before being further analyzed. To this end we regressed metabolite concentrations 17 
against storage times. After correcting for multiple testing, we found significant storage effects on 7 18 
metabolites (FDR < 0.05) (Fig S7). We, thus, corrected all further analyses for both storage time in 19 
the fridge and freezer, to avoid spurious results. Despite correcting all models for the storage time, 20 
we cannot ultimately eliminate a potential confounding effect due to storage time and future 21 
studies should investigate its influence on fecal metabolites. 22 
Microbial sequencing 23 
16S rRNA was extracted from fecal samples, PCR amplified, barcoded per sample and sequenced 24 
using the Illumina MiSeq, as previously described18. Reads were clustered in operational taxonomical 25 
units (OTUs) using the Sumaclust de novo approach and taxonomy was assigned by aligning 26 
representative sequences against the Greengenes 13_8 database35 (see supplemental methods for 27 
details). We excluded samples with less than 10,000 reads and OTUs that were observed in less than 28 
25% of all participants, leaving 581 OTUs for further analysis. OTU counts were converted to relative 29 
abundances and then log transformed, after a pseudo count of 10-6 was added to account for zero 30 
counts. The transformed abundances were adjusted for sequencing run, sequencing depth, 31 
individual who extracted the DNA, individual who loaded the DNA and sample collection method as 32 
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technical covariates using linear regression models. The residuals of these models were then used in 1 
downstream analysis of OTU abundances. The same normalization and control for technical effects 2 
was also carried out on taxonomic abundances collapsed at each taxonomic level. Collapsed 3 
taxonomies included counts from all OTUs. Shannon alpha diversity was also calculated from the 4 
complete OTU table. Each sample was rarefied to a depth of 10,000 reads 50 times and Shannon 5 
diversity was calculated as the average Shannon diversity across the 50 tables. Beta diversity was 6 
calculated from all OTUs excluding singletons using the unweighted UniFrac algorithm29. 7 
Statistical analysis 8 
To assess the influence of age and gender on metabolite measurements, we regressed all 9 
metabolites against age and gender, correcting for family structure as random intercept. Moreover, 10 
we calculated linear and logistic regression models, respectively, to assess the relationship of the 11 
fecal metabolome with obesity, measured as BMI and visceral fat mass (measured by double X-ray 12 
absorptiometry, see supplementary methods), respectively adjusting for age, sex, storage time and 13 
family as random intercept (see supplemental methods for formulas). Visceral fat measurements 14 
were available for 647 individuals. 15 
Heritability analysis 16 
We used structural equation modelling to estimate the genetic (A), the common environment (C) 17 
and the unique environment (E) components of the total variance for each metabolite36. To this end 18 
we used the R package mets (version 1.1.1) to fit maximum-likelihood models, adjusting for age and 19 
sex and storage time. For each metabolite we fitted four models, estimating (1) A, C and E 20 
components (2) A and E components, (3) C and E components and (4) E component only. The best 21 
model was selected by minimizing the Akaike Information Criterion (AIC). In case of dichotomous 22 
metabolite abundances, a liability-threshold model was fitted using the bptwin function of the mets 23 
package.  24 
Genome-wide association study 25 
Genetic variation was measured using whole genome sequencing, as previously described (Nature 26 
genetics, in revision). In brief, samples were sequenced using the Illumina HiSeqX sequencer with 27 
150 base paired reads. Reads were then mapped to hg38 genome using ISIS Analysis Software (v. 28 
2.5.26.13; Illumina) and missing genotypes were filled in with reference homozygous calls37. 29 
Genomes with a ratio of heterozygous to homozygous variants higher than 2.5 were excluded 30 
leaving 739 individuals for further analysis. A cohort-based high confidence region of the genome 31 
was constructed by concatenating positions with greater than 90% “PASS” call rate using data from 3 32 
sets of 100 randomly selected genomes. Variants outside of the high confidence region and 33 
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duplicated variants were removed. We moreover excluded 273,355 variants with Hardy-Weinberg 1 
p<10-6, calculated from 420 unrelated individuals, leaving 8,208,502 biallelic SNPs and 1,408,051 2 
InDels with minor allele frequency higher than 1% for further analysis.  3 
We fitted linear mixed models to test for associations of heritable fecal metabolites with genetic 4 
variants, correcting for age, sex, storage time using GEMMA38 incorporating data from 739 5 
individuals with fecal metabolomics and sequencing data. The twin structure of our data was taken 6 
into account by adjusting for the family relatedness using the sample kinship matrix. The score test 7 
implemented in GEMMA was used to assess significance of the associations. We considered 8 
metabolite-associations with a p-value lower than 1.2×10-10 significant, which corresponds to a 9 
genome-wide significance cut-off of 5.0×10-8, corrected for 428 tested metabolites. Additionally, we 10 
tested for genetic associations with all pairwise metabolite ratios of fecal metabolites with known 11 
chemical identity and a heritable variance component. We used the p-gain statistic to assess 12 
independence of the single metabolites19. The p-gain is defined as the minimal p-value of the 13 
associations of either of the single metabolites divided by the p-value of the metabolite ratio. A high 14 
p-gain statistic indicates that the ratio carries additional information compared to individual 15 
metabolites. We considered metabolite ratios with p < 1.6×10-12 (= 5×10-8 / 31,226 metabolite ratios) 16 
and p-gain > 3.1×105 (= 10 × 31,226 metabolite ratios) significant. 17 
Four genome-wide significant associations were replicated in 230 individuals of the TwinsUK study, 18 
adjusting for the same confounding factors. Results of discovery and replication were combined 19 
using fixed-effects inverse variance meta-analysis. 20 
Associations of the fecal metabolome with the gut microbiome 21 
To assess associations of the fecal metabolome with the gut microbiome, we first regressed 22 
metabolite concentrations against the Shannon alpha diversity, adjusting for age, sex, BMI, storage 23 
time and family structure using 644 individuals with both fecal metabolomics and 16S sequencing 24 
data available. 25 
We then estimated the proportions of variance of each metabolite explained by the microbiome by 26 
fitting restricted maximum likelihood (REML) models regressing the fecal metabolite concentration 27 
against the microbial alpha-diversity using the R-package regress. This technique is commonly used 28 
to estimate heritability from genetic kinship matrices39,40 (see supplemental methods for details).  29 
Next, we aimed to identify microbes and taxonomical units that are associated with metabolite 30 
levels. To this end we regressed 581 inverse normalized operational taxonomic units (OTUs) against 31 
all 915 metabolites, adjusting for age, sex, BMI, sample storage times, family structure and the alpha 32 
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diversity. Benjamini-Hochberg correction was applied to account for multiple testing. We further 1 
calculated associations at different taxonomical units, from genus to phylum level. 2 
Lastly, to assess multivariate dependencies between the fecal metabolome and the microbiome, we 3 
inferred a graphical model combining 423 metabolites with known chemical identity that were 4 
observed in at least 80% of the samples with 241 OTUs that were assigned complete taxonomy at 5 
least to the genus level. Sparse graphical models were inferred using the GeneNet package41 and 6 
edges with false discovery rate < 0.05 were included in the model. We used the Fruchterman-7 
Reingold algorithm42 to determine an unbiased graph layout and identified network modules by 8 
optimizing the modularity score as implemented in the igraph package43 (see supplemental methods 9 
for further details). 10 
Pathway enrichment 11 
We used pathway annotation as provided by Metabolon for pathway enrichment using the page 12 
algorithm. Enrichment p-values were estimated using permutation tests with 10,000 random 13 
permutations as implemented in the R-package piano44. 14 
Data availability 15 
16S sequencing data used for this study is deposited in the European Nucleotide Archive 16 
(ERP015317). All other TwinsUK data are available upon request on the department website 17 
(http://www.twinsuk.ac.uk/data-access/accessmanagement/).  18 
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Tables 1 
Table 1. Genetic associations of fecal metabolites 2 
Three metabolites and one metabolite ratio significantly associated with genetic loci in the discovery 3 
cohort. We report their respective heritabilities (H2), the associated variant along with its 4 
chromosomal position and the nearest gene, and the effect (+- its standard error) and p-value in the 5 
discovery and replication cohorts as well as the meta-analysis. The p-gain describes the strength of 6 
the association of the metabolite ratio relative to the associations of each individual metabolite. 7 
Metabolite H2 MAF SNP Chr Position Gene Effect P p-gain Effect (Repl) P (Repl) Effect (meta) P (meta) 
1,3-dimethylurate/       
5-acetylamino-6-
amino-3-
methyluracil 
40.2% 24.7% rs35246381 8 1841502
5 
NAT2 -0.17 (+-0.02) 7.0×10-21 7.5×109 -0.22 (+-0.03) 3.5×10-10 -0.18 (+-0.01) 3.3×10-36 
3-hydroxyhexanoate 20.7% 3.7% rs62311177 4 9296200
4 
GRID2 0.41 (+-0.06) 2.9×10-12  0.07 (+-0.09) 0.429 0.32 (+-0.05) 3.0×10-11 
eicosapentaenoate 
(EPA; 20:5n3) 
16.1% 1.4% rs149572251 20 3432293
6 
ITCH 1.45 (+-0.21) 3.4×10-11  -0.23 (+-0.38) 0.544 1.06 (+-0.18) 6.8×10-9 
3-phenylpropionate 
(hydrocinnamate) 
23.9% 1.6% rs58539483 11 2883050
1 
AC0908
33.1 
-1.31 (+-0.19) 3.6×10-11  -0.39 (+-0.22) 0.076 -0.92 (+-0.14) 1.5×10-10 
 8 
 9 
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Figures 1 
Figure 1. Number of measured fecal metabolites. 2 
1116 metabolites were detected in 786 fecal samples. (A) 570 of those were detected in at least 80% of all samples 3 
and 345 were detected in less than 80% but more than 20% of all samples. The first were analyzed continuously, 4 
while we dichotomized the latter in present/absent. 210 metabolites that were present in less than 20% of the 5 
samples were excluded from further analysis. (B) 469 metabolites where observed in both, fecal and blood samples 6 
of the sample individuals, while 647 metabolites are unique to feces. 499 of these 647 metabolites were observed in 7 
at least 20% of the fecal samples. 8 
A) Frequencies of fecal metabolites.  9 
 10 
 11 
B) Overlap of fecal and blood metabolome. 12 
 13 
 14 
  15 
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Figure 2. Association of the fecal metabolome with age. 1 
While we found the fecal metabolome stable during adulthood, we found the oldest decile of our study population 2 
(>75 yrs.) different from the youngest decile (<56 yrs.) of the study population. We first investigated the age effect 3 
for all metabolites individually (A) and found one metabolite, phytanate, significantly between the youngest and the 4 
oldest decile of our data. We then fitted a multivariate PLS-DA model to distinguish the older from the younger 5 
group (B). We estimated the area under the receiver operations curve (AUC) at 0.71 (p=6.8×10-6) in a 10-fold cross-6 
validation setting. 7 
A) qq-plot of associations of metabolites and age deciles B) PLS-DA discriminating older from younger adults 
  
 8 
 9 
10 
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Figure 3. Associations of fecal metabolites with gut microbiome correspond to microbial effect on 1 
visceral fat. 2 
Visceral fat mass was significantly associated with 43 fecal amino acids (all positively) and 32 OTUs (6 positively in 3 
orange, 26 negatively in green). Red tiles indicate positive associations between these metabolites and OTUs (β > 0) 4 
and blue tiles negative associations (β < 0); grey tiles indicate non-significant associations (FDR > 5 %). Microbial 5 
associations with fecal metabolites correspond to their respective associations with visceral fat, indicating that the 6 
microbial metabolic profile is more closely related to the host phenotype than taxonomy.  7 
 8 
 9 
  10 
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Figure 4. Intraclass correlation of fecal metabolites in MZ and DZ twins. 1 
The intraclass correlation was calculated separately for monozygotic (MZ) and dizygotic (DZ) twins for each 2 
metabolite. Positive values of their respective differences indicate more similar metabolic profiles between MZ than 3 
DZ twins. 4 
 5 
  6 
20 
 
Figure 5. Host genetic influence on the fecal metabolome 1 
(A) Manhattan plot of genome wide p-value from association analysis of fecal metabolites in the discovery sample. 2 
horizontal line indicates the Bonferroni cutoff of 1.2×10-10. Three metabolites pass the Bonferroni threshold. (B) 3 
Manhattan plot of genome wide p-value from association analysis of metabolite ratios in the discovery sample. The 4 
horizontal line indicates the Bonferroni cutoff of (p<1.6×10-12). Two ratios pass the threshold, however only 1,3-5 
dimethylurate / 5-acetylamino-6-amino-3-methyluracil (p = 6.2×10-21) passed filtering by p-gain (p-gain > 8.9×105) 6 
and thus is considerably stronger than the association of each individual metabolite. Boxplots, QQ-plots, and 7 
regional association plots for each of the four loci are shown in Supplemental Fig S2-S4. 8 
A)  
 
B)  
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